Although pharmacogenetics is a promising field that already contributed to a better understanding of some of the underlying mechanisms of action of drugs used in IBD , the only discovery translated until now into daily practice is the relation between thiopurine S-methyltransferase ( TPMT ) gene polymorphisms and hematological toxicity of thiopurine treatment .